Key result
Serum adiponectin was not significantly correlated with insulin sensitivity (adjusted r = 0.04) and was not acutely affected by hyperinsulinemia, oral glucose, or fat load in healthy participants.
Why the study?
Do acute metabolic procedures (hyperinsulinemia, oral glucose, oral fat load) affect serum adiponectin levels in healthy participants?
Do acute metabolic procedures (hyperinsulinemia, oral glucose, oral fat load) affect serum adiponectin levels in healthy participants?
Effect estimate: r = 0.25
In healthy participants, serum adiponectin is strongly associated with lipid metabolism rather than insulin sensitivity and remains stable during acute metabolic challenges.
Does not support adiponectin as an acute insulin-sensitivity marker in health; leaves open its role in lipid metabolism or disease states.
BACKGROUND: Adiponectin is a recently discovered plasma protein with many associations to glucose and lipid metabolism. Due to its central role in cardiovascular diseases and insulin resistance, we studied the relationship between serum adiponectin and factors reflecting glucose and lipid metabolism. METHODS AND RESULTS: Thirty healthy participants (20M/10F, age 32.0 +/- 2.1 years, BMI 25.8 +/- 0.9 kg/m (2) and HbA (1c) 5.2 +/- 0.1 %) were studied four times at approximately one week intervals. The effects of a 4-hour euglycemic hyperinsulinemia (40 mU/m (2)/min), saline infusion (control), oral glucose, and oral fat load on serum adiponectin were studied. No significant correlation was found between serum adiponectin and insulin sensitivity before (r = 0.25) or after adjustment for age, BMI and gender (r = 0.04). Adiponectin concentration correlated inversely with HbA (1c) (r = - 0.43, p < 0.05), insulin concentration (r = - 0.38, p < 0.05) and triglyceride concentration (r = - 0.42, p < 0.05) but positively with HDL cholesterol (r = 0.38, p < 0.05). Metabolic procedures had no effect on serum adiponectin. CONCLUSIONS: Our findings favor the interpretation that adiponectin is not causally related to insulin sensitivity in healthy participants. The strongest associations of adiponectin in healthy participants are to be found to lipid metabolism. Serum levels of adiponectin are very stable and not acutely affected by hyperinsulinemia, oral glucose or fat load.
No takes yet. Share an insight, caveat, or question.
Heliövaara et al. (2006) studied Healthy (n=30). Euglycemic hyperinsulinemia, oral glucose, and oral fat load vs. Saline infusion was evaluated on Correlation between serum adiponectin and insulin sensitivity (r = 0.25). Serum adiponectin was not significantly correlated with insulin sensitivity (adjusted r = 0.04) and was not acutely affected by hyperinsulinemia, oral glucose, or fat load in healthy participants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: